Billionaire Stanley Druckenmiller Continues to Load Up on Revolution Medicines. Does He Know Something Wall Street Doesn't?
Key PointsDruckenmiller added roughly 26.5% to his position in Revolution Medicines in Q2.
Legendary investor Stanley Druckenmiller has been steadily increasing his stake in Revolution Medicines, a biotech company that has yet to generate significant near-term growth according to analysts. Druckenmiller's ability to consistently generate returns for his investors over a 30-year span, including during tumultuous periods like the dot-com bubble burst and the 2008 financial crisis, is well-known.
However, he parted ways with Duquesne Capital Management in 2010. Druckenmiller still oversees the Duquesne Family Office, a private investment firm handling his and his family's funds. His continued interest in Revolution Medicines has led some to wonder if he possesses insider knowledge that Wall Street is missing.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
